Loading...
XASX
HYD
Market cap2mUSD
Jul 03, Last price  
0.02AUD
1D
7.14%
1Q
-16.67%
Jan 2017
-97.06%
IPO
-99.66%
Name

Hydrix Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
0.39
EPS
—
Div Yield, %
—
Shrs. gr., 5y
100.54%
Rev. gr., 5y
-5.60%
Revenues
11m
-19.38%
267,120135,007113,478169,110020,60110,77131,17515,16719,055170,27998,46430,2465,708,16214,150,35314,934,2257,445,22110,325,01813,156,57210,607,103
Net income
-10m
L+2,308.22%
-363,567-727,105-13,771,134-2,478,616-1,805,685-956,875-3,706,097-1,466,408-1,651,383-1,419,513-4,020,406-4,880,714-4,375,949-5,080,967-4,219,742-3,219,461-9,778,693-5,546,389-396,926-9,558,852
CFO
-2m
L-39.40%
-86,677-273,037-397,802-1,149,705-959,191-805,998-1,378,048-1,433,803-615,052-1,090,627-2,950,792-2,855,566-2,764,828-3,809,272-4,197,025-1,316,565-2,861,522-6,581,789-3,121,313-1,891,650
Earnings
Aug 28, 2025

Profile

Hydrix Limited provides product design, engineering, and regulatory services in Australia, Singapore, Europe, North America, and internationally. It operates through two segments: Hydrix Services and Hydrix Medical. It provides cardiovascular products, such as The GUARDIAN, a cardiac monitoring and alerting device that reduces the stresses of living; Phyzhon PHYRARI FFR-Wire enables cardiologists to combine diagnosis procedures with delivery of therapy including stents; and LUDO, a customizable plug-and-play platform that provides critical tools to start MCS pump development. The company also offers a range of services, including product development, regulatory and clinical consulting, and technology commercialization. It serves medical, consumer, industrial, utilities, defense, aerospace, and mining industries. The company was formerly known as Panorama Synergy Limited and changed its name to Hydrix Limited in November 2018. Hydrix Limited was incorporated in 1993 and is headquartered in Mulgrave, Australia
URL
https://www.hydrix.com/
IPO date
May 11, 2001
Employees
70
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
10,607
-19.38%
13,157
27.42%
Cost of revenue
12,051
26,228
Unusual Expense (Income)
NOPBT
(1,444)
(13,072)
NOPBT Margin
Operating Taxes
(67)
Tax Rate
NOPAT
(1,444)
(13,004)
Net income
(9,559)
2,308.22%
(397)
-92.84%
Dividends
Dividend yield
Proceeds from repurchase of equity
2,562
BB yield
-41.19%
Debt
Debt current
2,967
2,224
Long-term debt
6,893
4,014
Deferred revenue
Other long-term liabilities
433
357
Net debt
5,529
192
Cash flow
Cash from operating activities
(1,892)
(3,121)
CAPEX
(14)
(200)
Cash from investing activities
(53)
(210)
Cash from financing activities
1,707
2,543
FCF
(201)
(14,348)
Balance
Cash
914
1,153
Long term investments
3,416
4,894
Excess cash
3,800
5,389
Stockholders' equity
(3,355)
6,353
Invested Capital
8,038
6,053
ROIC
ROCE
EV
Common stock shares outstanding
254,219
239,245
Price
0.01
-46.15%
0.03
-64.86%
Market cap
3,559
-42.78%
6,220
-57.18%
EV
9,088
6,412
EBITDA
(501)
(11,753)
EV/EBITDA
Interest
699
446
Interest/NOPBT